Article date: 1988/1/12
PubMed ID: 2830944
Journal name: Brain research (ISSN: 0006-8993)
Intranigral gamma-vinyl-GABA (GVG) suppresses electroshock seizures (ES). This anticonvulsant action was blocked by systemic treatment with the alpha 2-antagonist idazoxan. Consequently, we tested the idea that intranigral GABA mimetics suppress ES by increasing noradrenergic (NE) neuronal activity. Contrary to our hypothesis, GVG decreased NE turnover. This result indicates that while the seizure-suppressant effect of intranigral GVG requires alpha 2-mediated NE neurotransmission, the mechanism of this anticonvulsant action is not by increasing NE neuronal activity.
Author List: Bonhaus D W, McNamara J O
Publication Types: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
Substances mentioned in the article: Aminocaproates; Anticonvulsants; Dioxanes; Dioxins; Receptors, Adrenergic, alpha; Muscimol; Dihydroxyphenylalanine; Vigabatrin; Idazoxan;
Mesh terms: Aminocaproates/pharmacology; Animals; Anticonvulsants/pharmacology; Dihydroxyphenylalanine/metabolism; Dioxanes/pharmacology; Dioxins/pharmacology; Idazoxan; Muscimol/pharmacology; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha/drug effects; Seizures/physiopathology; Spinal Cord/drug effects; Substantia Nigra/drug effects; Vigabatrin;